Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels

Type 2 diabetes mellitus (T2DM) constitutes a major portion of Jordan’s disease burden, and incidence rates are rising at a rapid rate. Due to variability in the drug’s response between ethnic groups, it is imperative that the pharmacogenetics of metformin be investigated in the Jordanian population...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Eitan, Laith N., Almomani, Basima A., Nassar, Ahmad M., Elsaqa, Barakat Z., Saadeh, Nesreen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462993/
https://www.ncbi.nlm.nih.gov/pubmed/30934600
http://dx.doi.org/10.3390/jpm9010017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462993/
https://www.ncbi.nlm.nih.gov/pubmed/30934600
http://dx.doi.org/10.3390/jpm9010017

Ejemplares similares